SCHEMBL3301599

SCHEMBL3301599

Cc1cccc([SiH](O[SiH](c2cccc(C)c2)c2cccc(C)c2)c2cccc(C)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.50
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 1/20 0.41
IDO1 P14902 2/20 0.38
TP53 P04637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 1/20 0.36
NPC1 O15118 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3299926 0.94 ACHE (0.44) ACHEALDH1A1MAPK1IDO1LMNA
SCHEMBL782849 0.77 ACHE (0.58) ACHEALDH1A1MAPK1IDO1TP53
SCHEMBL29776858 0.75 ACHE (0.55) ACHEALDH1A1MAPK1IDO1TP53
SCHEMBL6332350 0.75 ACHE (0.55) ACHEALDH1A1MAPK1IDO1TP53
SCHEMBL8762344 0.74 ACHE (0.48) ACHEALDH1A1MAPK1IDO1TP53
SCHEMBL3296741 0.74 ALDH1A1 (0.38) ACHEALDH1A1MAPK1TDP1CYP3A4
SCHEMBL31598845 0.73 ACHE (0.52) ACHEALDH1A1MAPK1IDO1TP53
SCHEMBL3294227 0.73 ACHE (0.50) ACHEALDH1A1IDO1NPC1CYP1A2
SCHEMBL3294404 0.71 ACHE (0.46) ACHEALDH1A1TDP1LMNANPC1
SCHEMBL2455938 0.71 ACHE (0.50) ACHEALDH1A1MAPK1TP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 ACHE 3477/4885ALDH1A1 1865/4885MAPK1 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.